The Wayback Machine - https://web.archive.org/web/20120223231830/https://en.wikipedia.org/wiki/2C-B-BZP

2C-B-BZP

From Wikipedia, the free encyclopedia
Jump to: navigation, search
2C-B-BZP
Systematic (IUPAC) name
1-(4-bromo-2,5-dimethoxybenzyl)piperazine
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
ATC code  ?
ChemSpider 26234933 YesY
Chemical data
Formula C13H19BrN2O2 
Mol. mass 315.2085 g/mol
SMILES eMolecules & PubChem
 YesY(what is this?)  (verify)

4-Bromo-2,5-dimethoxy-1-benzylpiperazine (2C-B-BZP) is a psychoactive drug and research chemical of the piperazine chemical class which has been sold as a "designer drug".[1][2] It produces stimulant effects similar to those of benzylpiperazine (BZP).

Contents

[edit] Chemistry

2C-B-BZP contains a benzylpiperazine base as well as the ring-substitution pattern of the psychedelic phenethylamine 2C-B, although 2C-B-BZP is not a phenethylamine itself and does not produce psychedelic effects as the binding groups are in the wrong position to activate the 5-HT2A receptor.

[edit] Effects

2C-B-BZP produces stimulant effects which last 3-6 hours. It is also said by several sources to increase the effects of other compounds when combined. Side effects include headaches and nausea, similar to those of other recreationally-used piperazine derivatives.

[edit] Legality

2C-B-BZP is unscheduled and uncontrolled in the United States, but possession and sale of 2C-B-BZP could possibly be prosecuted under the Federal Analog Act because of its structural similarities to benzylpiperazine. 2C-B-BZP is said to be illegal to possess, use or sell in Japan where it used to be sold in local smartshops.

[edit] See also

[edit] References

  1. ^ Westphal F, Junge T, Girreser U, Stobbe S, Pérez SB (May 2009). "Structure elucidation of a new designer benzylpiperazine: 4-bromo-2,5-dimethoxybenzylpiperazine". Forensic Science International 187 (1-3): 87–96. doi:10.1016/j.forsciint.2009.03.003. PMID 19345524. 
  2. ^ Peters FT, Martinez-Ramirez JA (October 2010). "Analytical toxicology of emerging drugs of abuse". Therapeutic Drug Monitoring 32 (5): 532–9. doi:10.1097/FTD.0b013e3181f33411. PMID 20814349. 


Personal tools
Namespaces
Variants
Actions
Navigation
Interaction
Toolbox
Print/export
Languages
Morty Proxy This is a proxified and sanitized view of the page, visit original site.